Spilling the Blood of a Silicon Valley Unicorn | Tyler Shultz and Erika Cheung: 2019 — Transcript
Full transcript
- 0:06Good evening and welcome.
- 0:08My name is Colin Anthony and I'm the
- 0:10associate director for undergraduate
- 0:12outreach for the Center for Ethics and
- 0:14Society here at Stanford University.
- 0:17Our center aims to encourage and promote
- 0:20ethical reflection through not only
- 0:22research and scholarship in the
- 0:23classroom, but also through student
- 0:25engagement and community events such as
- 0:28this one this evening.
- 0:31In planning this event, I have had the
- 0:33unique privilege of working with many
- 0:35undergraduate university leaders on
- 0:38campus without whom this event would not
- 0:40have been possible.
- 0:42This includes our co-sponsors of
- 0:44tonight's event,
- 0:45the student group CS + Social Good.
- 0:49Founded in 2013,
- 0:51this group offers leadership
- 0:53opportunities that range from summer
- 0:55fellowships at the Haas Center for
- 0:56Public Service,
- 0:58and opportunities for courses where
- 1:00students can build projects for
- 1:02nonprofit organizations.
- 1:05In my work with CS + Social Good, I have
- 1:08been constantly amazed and by the
- 1:10passion, rigor, and commitment that
- 1:13undergraduates have brought to the
- 1:15table. And so I urge undergraduates in
- 1:18the audience here to reach out to me if
- 1:20you have an idea that that connects
- 1:23ethics and society that you would like
- 1:25to see um envisioned in society and at
- 1:28this university. So please reach out to
- 1:30our center and reach out to CS + Social
- 1:32Good if you have any ideas that you
- 1:34would like to work on and and become a
- 1:35reality.
- 1:38Before moving forward, I want to share
- 1:40with you the format of this evening's
- 1:42event.
- 1:43First, I will turn it over to Alexander
- 1:45Lamb, an undergraduate who's affiliated
- 1:48with the center, who's going to be
- 1:49giving a sort of brief overview
- 1:51presentation of the Theranos saga before
- 1:53introducing our speakers.
- 1:56The interview is set to conclude at 8:00
- 1:59p.m., after which there will be a Q&A
- 2:01period for 30 minutes.
- 2:04I will allow for specific audience
- 2:07members if they need to leave at 8:00
- 2:08p.m. to exit the auditorium during that
- 2:10time.
- 2:11At 8:00
- 2:12after the interview concludes, there
- 2:14will be microphones in each of the
- 2:16aisles, as well as a microphone in the
- 2:18balcony, and at that time I will ask you
- 2:20to line up for question and answers.
- 2:24With that said, please join me in
- 2:26welcoming Alexander Lamb, an
- 2:28undergraduate and affiliate with the
- 2:29Center of Ethics and Society, who will
- 2:31guide us through the story of Theranos
- 2:33and then introduce our our speakers.
- 2:36Alexander?
- 2:44Hi, good evening everyone and thank you
- 2:46for joining us tonight. I'm very excited
- 2:48to be here.
- 2:49I'd like to begin tonight's event with a
- 2:51photo.
- 2:53Uh one second.
- 2:56Four years ago, Elizabeth Holmes, the
- 2:58CEO and founder of Theranos, sat in this
- 3:01very auditorium.
- 3:03Here she promised to deliver technology
- 3:05that would revolutionize the healthcare
- 3:07industry in the 21st century.
- 3:09The idea behind her technology was
- 3:11simple, yet groundbreaking.
- 3:14With only a single prick of blood,
- 3:16patients could gain access to hundreds
- 3:18of blood test results and use them to
- 3:20make important medical decisions.
- 3:23As shown here on the cover of Forbes
- 3:24magazine, Elizabeth Holmes is holding
- 3:26what she called a nanotube of blood
- 3:29between her very fingers.
- 3:31Because of this technology's potential
- 3:33impact on the health of millions of
- 3:35people, she claimed that it was {quote}
- 3:37the most important thing humanity has
- 3:39ever built.
- 3:41This vision gripped the imagination of
- 3:43Silicon Valley and attracted influential
- 3:45figures to support her company,
- 3:47including the former US Secretary of
- 3:49State George Shultz, who is the
- 3:51grandfather of one of our guests
- 3:52tonight, Tyler Shultz.
- 3:54She also convinced investors such as
- 3:56Rupert Murdoch of the Fox News
- 3:58Corporation and the Walton family of
- 4:00Walmart to back her company.
- 4:02At its peak, Theranos was valued at over
- 4:05$9 billion
- 4:06and Elizabeth Holmes was named the
- 4:08world's youngest self-made female
- 4:10billionaire.
- 4:12Heralded as the next Steve Jobs, she
- 4:14dressed in black turtlenecks and
- 4:15described her technology as the iPod of
- 4:18healthcare.
- 4:19However, despite her lofty promises and
- 4:22celebrity status, there were deep flaws
- 4:24in both her technology and business
- 4:26practices.
- 4:28In her relentless pursuit of success,
- 4:30she manipulated lab results, deceived
- 4:32government inspectors, and instilled a
- 4:35crippling fear in her employees as she
- 4:37struggled to hide the fact that the
- 4:39technology she promised was simply not a
- 4:41reality.
- 4:43In fact, in a brazen case of deception,
- 4:45Elizabeth Holmes guided Joe Biden
- 4:48through what turned out to be a fake
- 4:49laboratory with staged equipment in an
- 4:52attempt to convince the public that her
- 4:54technology was ready and that she could
- 4:56be trusted.
- 4:58Her ruse had worked. In 2013, despite
- 5:01glaring deficiencies in Theranos's
- 5:03faulty technology, Elizabeth Holmes
- 5:05scaled out products to neighborhood
- 5:07Walgreens stores, where patients made
- 5:09serious medical decisions on the basis
- 5:11of dubious tests.
- 5:14Uh many stories emerged of people
- 5:17receiving diagnoses for conditions that
- 5:19they simply did not have, which
- 5:21bewildered medical professionals and
- 5:23frightened patients.
- 5:25But for the employees inside Theranos,
- 5:27some of them had seen enough, which
- 5:29brings us to the real story of tonight,
- 5:32the story of two courageous individuals,
- 5:34Erika Cheung and Tyler Shultz, who in
- 5:37their very first jobs after college
- 5:39risked their personal and professional
- 5:41lives to stand for what is right.
- 5:43As we hear and learn from their
- 5:45experiences this evening, they will
- 5:47surely serve as an important reminder to
- 5:49us all for what happens when myth is
- 5:51mistaken for reality and when values are
- 5:54divorced from technology.
- 5:56And interviewing our two guests tonight
- 5:58with questions from many of you in the
- 6:00audience will be Sasank Munukutla, an
- 6:02undergraduate here at Stanford and
- 6:04member of the student group CS + Social
- 6:06Good. So without further ado, please
- 6:08join me in welcoming Erika, Tyler, and
- 6:11Sasank to the stage.
- 6:16Well, Erika and Tyler, on behalf of the
- 6:18Stanford community, I would like to
- 6:19thank you for being here today. Um
- 6:21Thanks for having us. Yeah, thanks for
- 6:22having us. There has certainly has been
- 6:24a lot of excitement around campus to
- 6:26hear from you.
- 6:27Now, Alexander earlier mentioned um that
- 6:30Elizabeth Holmes sat here right in your
- 6:32chair in Cemex Auditorium not too long
- 6:35ago.
- 6:37How do you feel about that?
- 6:39Um considering the seat she was sitting
- 6:41in today, I hope the trend stops here.
- 6:45Yeah.
- 6:46Yeah.
- 6:47Yeah, it's it's a bit surreal, honestly.
- 6:49Like uh you never would have expected by
- 6:52joining Theranos that this is what would
- 6:54have happened. I never expected that,
- 6:57you know, I'd enter into a company that
- 6:59ended up being a big fraud case.
- 7:02So, yeah, it's a bit surreal.
- 7:05As a student myself and a lot of us in
- 7:07the audience today are students, I would
- 7:09like you to think back to college. What
- 7:11were your experiences like and what drew
- 7:13you to Theranos as your first real job
- 7:15after college?
- 7:18Do you want me to go with this one?
- 7:20Okay.
- 7:21Yeah, so I a little bit of background, I
- 7:23studied molecular and cell biology and
- 7:25linguistics and I was on the academic
- 7:29track. So I was trying
- 7:31to see about getting a PhD after
- 7:33college, but had kind of become a little
- 7:35disillusioned with academia and uh
- 7:39fell in love with like the vision of
- 7:41Theranos that it was like getting
- 7:43research that was in a lab and making it
- 7:45into a commercialized product.
- 7:47Um and was super sold on the vision,
- 7:51totally drank the Kool-Aid initially,
- 7:54uh you know, making healthcare more
- 7:56accessible and affordable
- 7:59um was kind of right up my alley and
- 8:02how cool would it be to work for a tech
- 8:04company in the Silicon Valley, right?
- 8:06The place to be for technology. So that
- 8:09kind of drew me to Theranos and also
- 8:11Elizabeth Holmes drew me to Theranos.
- 8:13From the little that I'd read on the
- 8:14media,
- 8:16um having a really strong female
- 8:18entrepreneur who was um
- 8:22basically worked very hard to start her
- 8:24own company
- 8:26uh was really appealing to me and so
- 8:28that's why I decided to go working with
- 8:30Theranos. I had other two other job
- 8:32opportunities actually at Stanford and
- 8:34UCSF, but I turned them both down to to
- 8:36work for Theranos, so.
- 8:38Yeah,
- 8:39so when I started working at Theranos,
- 8:41that was after my junior year of
- 8:42college, actually. So I was a junior at
- 8:45Stanford majoring in mechanical
- 8:47engineering and then I actually met
- 8:49Elizabeth Holmes and I totally fell in
- 8:52love with her vision and changed my
- 8:55major to biology so I could do some more
- 8:57chemistry and um
- 8:59yeah, I I was only a bio major for two
- 9:01quarters, but I ended up graduating
- 9:03graduating biology and then going to
- 9:04Theranos.
- 9:07Could you tell us more about both of
- 9:09your roles at Theranos? What did your
- 9:11work entail?
- 9:12Uh so I started out in protein
- 9:15engineering, so I was developing
- 9:16antibodies that would be used in the
- 9:18tests, but four days after I started
- 9:20doing that job full-time, they actually
- 9:21shut down all the research labs and put
- 9:24us all into what was called the assay
- 9:26validation team. Um and the reason that
- 9:29I was told was that that team was like
- 9:3120 people and then dropped down to like
- 9:33eight people super quickly cuz they were
- 9:35working, you know, through the night.
- 9:38Um
- 9:39and
- 9:41yeah, so then I moved into assay
- 9:43validation
- 9:44uh where our goal was really to take a
- 9:46test and make sure that it was safe to
- 9:48use, you know, on on the general public.
- 9:52Yeah.
- 9:53Uh so I started off in research and
- 9:55development and that's where Tyler and I
- 9:56actually met. So, I was on the assay
- 9:58validation team as well. Um and as I
- 10:02started working with the company, they
- 10:04also did the same thing where they're
- 10:05like, "Actually, the clinical lab needs
- 10:07a lot of help. So, we're going to change
- 10:09your job role and you're going to work
- 10:10in the clinical lab." So, I was in
- 10:12charge of taking Theranos' proprietary
- 10:14devices that we were validating in
- 10:16research and development and then
- 10:18integrating it into the clinical lab.
- 10:21And the clinical lab, just to give
- 10:22everyone context, is where you process
- 10:24patient samples. So, that's regulated by
- 10:27the Center of Medicare
- 10:28Medicare and Medicaid services. Am I
- 10:31saying that right? And uh and the FDA.
- 10:35Sure. Um I think it was nice to hear
- 10:37from you that, you know, you were often
- 10:39moved between different teams. Other
- 10:41people described the culture of fear at
- 10:42the company. Entire divisions and teams
- 10:45were siloed away from each other with no
- 10:47communication between them. I'd love to
- 10:49hear more about that culture of fear at
- 10:52Theranos and what that meant for both of
- 10:53you personally.
- 10:55Yeah, so there would be like
- 10:57uh like barriers up that would surround
- 10:59where the devices were. So, even if you
- 11:00were in the lab, you still couldn't see
- 11:02the devices. So, like I worked there for
- 11:043 months and didn't see a single device.
- 11:07Um it wasn't until I moved uh into the
- 11:10assay validation team that I actually
- 11:12saw a device for the first time. And
- 11:14it's kind of crazy to think that you
- 11:15have like most of your company working
- 11:17towards something that they've never
- 11:19even seen.
- 11:20Um and that's how siloed it was. Um but
- 11:23I remember there was one funny
- 11:25one funny thing that happened where like
- 11:26a a light bulb went out. So, they had
- 11:28like an electrician come in and he
- 11:30stands on this like 12-ft ladder and
- 11:31puts in the light bulb where he can see
- 11:33over all of the barriers.
- 11:34Um so, I saw that happening and I just
- 11:36thought,
- 11:38I feel like those barriers are there
- 11:39like
- 11:41really for I don't know. It felt weird
- 11:43that they didn't care about the like
- 11:44like someone from the outside seeing. It
- 11:45seemed like it was a barrier to like
- 11:47make us like the employees realize um
- 11:50that they weren't supposed to to know
- 11:52things.
- 11:53It was also for the vendors too. I would
- 11:55talk to We had these machines called
- 11:57TECANs. They were these robotic liquid
- 11:59handling arms. And they'd find it so
- 12:01ridiculous cuz the moment you entered
- 12:03into Theranos, the first thing that they
- 12:04have you do is sign an NDA and sign like
- 12:08this sort of like if you do see
- 12:10anything, you are not allowed to
- 12:11disclose what you see inside there. And
- 12:14this was for vendors, new employees. Um
- 12:17and by the time you were employee,
- 12:19you've already signed a contract that
- 12:21you cannot disclose anything uh that
- 12:23you've seen within those those halls.
- 12:25But, yeah, there were all these weird
- 12:29man-filled obstructions. Sometimes
- 12:31they'd be escorted all throughout the
- 12:34building with like two security guards
- 12:36to make sure that they didn't see
- 12:37anything. I actually remember that when
- 12:39I first started, there was a list of
- 12:41words they gave me that I was not
- 12:42allowed to say when describing my job.
- 12:45Yeah. And I don't remember exactly what
- 12:47was on the list, but it was like
- 12:48pipette, research, biology.
- 12:51Yeah, that's right.
- 12:53Yeah. Okay.
- 12:55And you couldn't put it on LinkedIn. You
- 12:57couldn't put it on anything. Which was
- 12:59funny because when all this stuff blew
- 13:00up, we had to say we were part of a
- 13:02private biotech company. So, you almost
- 13:04always knew that someone worked at
- 13:05Theranos because they probably had
- 13:07private biotech company on their
- 13:09LinkedIn profile. Um
- 13:12Um but then they had a really intense
- 13:13work culture as well. Like Sunny, the
- 13:15president of the company, would walk
- 13:16through the labs like 3:00 in the
- 13:18morning to make sure people were there
- 13:19working.
- 13:20Um
- 13:22Yeah. Yeah. Just very intense place. And
- 13:25a lot of people were scared of losing
- 13:26their jobs. You know, all these people
- 13:28had families that they needed to support
- 13:30and feed. And so, constantly
- 13:34feeling the pressure of needing to make
- 13:37Sunny and Elizabeth happy and produce
- 13:39whatever results that they needed to
- 13:41kind of further whatever initiatives
- 13:44that they seemed to have come up with
- 13:46those days. There was a lot of pressure
- 13:48to perform and provide the the results
- 13:52that they needed. Uh and we had a lot of
- 13:56members of the team who weren't
- 13:57necessarily US citizens too. They were
- 13:59sponsored. They were scared that if they
- 14:01stopped working for Theranos, they would
- 14:02no longer have a visa.
- 14:04Um but there was a lot of pressure to
- 14:06get the results specifically that Sunny
- 14:08and Elizabeth wanted at at any cost. And
- 14:12really a sentiment that if you didn't
- 14:14produce, say, if you didn't get this
- 14:16assay validated and say that, you know,
- 14:18vitamin D is getting the perfectly
- 14:20accurate results, there was something
- 14:22wrong with you. There was nothing wrong
- 14:24with the technology, nothing wrong with
- 14:26uh
- 14:26you know, the chemistry. It was like you
- 14:28were not performing well and you weren't
- 14:30getting this done. Um was generally the
- 14:34the culture.
- 14:36Both of you discovered troubling results
- 14:39of various forms despite this culture of
- 14:41fear and managed to think through of
- 14:43those results on your own. What exactly
- 14:45did you find and how did you go about
- 14:47finding those troubling results?
- 14:51Yeah. I think we were talking about this
- 14:53backstage about when I started working
- 14:55for Theranos, it must've been like 2
- 14:57months in where I was really struggling
- 14:59with when did 2 + 2 = 6? Cuz this has
- 15:02never been a fact ever
- 15:06in all of my education. Um but there
- 15:09were simple things in research and
- 15:10development. We were watching people
- 15:12basically tamper with data. They were
- 15:13cherry-picking results. This is like
- 15:15fundamentals of scientific integrity.
- 15:18You show all the data. Even if it
- 15:19doesn't show the accuracy you want, the
- 15:22CVs you want, you keep it in there. And
- 15:25that provides you with the information
- 15:27to know I'm doing something wrong. But
- 15:29instead of taking those as signals of
- 15:32I'm doing something wrong, people would
- 15:34want to alter it to get better accuracy
- 15:36rates, to get better CVs. And so, that
- 15:39was the first kind of like, "What is
- 15:41going on here? I've never been in a
- 15:43laboratory where this has happened." Uh
- 15:46and then for me, because I had gone from
- 15:49research and development, research and
- 15:50development, you know things are going
- 15:52to go wrong. That's kind of your job is
- 15:55to fix the problems of what's going on.
- 15:57But then going into the clinical lab and
- 15:59taking what I'd seen not work and and
- 16:02just constantly being falsified and then
- 16:05putting it in a clinical setting where
- 16:07now I was having to test patients. And I
- 16:09was basically using these same tests
- 16:11that I saw not working in a research
- 16:13setting on patients, um
- 16:17started to raise even more red flags. In
- 16:20addition to watching inspectors come in
- 16:23and
- 16:24you know, Sunny and Elizabeth not
- 16:25showing them the actual technology we
- 16:27were using on patients and all these
- 16:29things. I'd only worked there to give
- 16:31her for 7 months. Right? So, it was
- 16:34pretty quick. Like probably about a
- 16:36month
- 16:38and a half in that I started seeing like
- 16:40something's not right here.
- 16:42Um
- 16:43but yeah, those were some of the
- 16:45instances. So, for me, my first red flag
- 16:47was the first time that I saw what they
- 16:49called the open reader. So, they had one
- 16:51reader where they didn't have a shell on
- 16:53it. So, you could actually see what the
- 16:54protocol was doing inside.
- 16:56So, when I first joined the assay
- 16:57validation team, they showed me and um
- 17:00a senior scientist, like my uh my boss
- 17:03from the engineer from the protein
- 17:04engineering lab, we saw it at the same
- 17:06time.
- 17:07And um you can immediately tell that
- 17:10nothing in there is is new. So, the
- 17:13senior scientist looked at the person
- 17:14who was demoing the device and said,
- 17:16"Do you think this is very cool?" And
- 17:18then the woman who's giving me the demo
- 17:20just went,
- 17:21"I'll let I'll let you decide for
- 17:23yourself if you think this is cool." and
- 17:24walked away. And at that point I like I
- 17:26kind of realized that it was this like
- 17:27open secret that it wasn't real.
- 17:31Um and then I started working with the
- 17:32devices and going to these daily
- 17:34meetings where we would go over the data
- 17:36from the day before and you quickly fall
- 17:38into the habit of just deleting
- 17:41experiments that don't look good. Even
- 17:42just parts of experiments that don't
- 17:44look good. We would go through the
- 17:45meeting and go, "Oh, that looks weird.
- 17:46Let's rerun those. Let's rerun."
- 17:48Everything was okay, what do we need to
- 17:49rerun? And we just rerun it. So, you
- 17:51delete it, repeat and repeat it, fill in
- 17:54the data with the new with the newly
- 17:56collected data.
- 17:57Um
- 17:59and then for me, a big red flag,
- 18:01probably the biggest red flag, was when
- 18:02we were doing this for the syphilis test
- 18:04and I was doing what they called
- 18:06precision testing. So, I ran the same
- 18:08sample over and over to see how much
- 18:10variation there was.
- 18:11And I found that at our cutoff level,
- 18:13there was a 43% coefficient of
- 18:16variation. So, the standard deviation
- 18:18was 43% of the expected value or the
- 18:20mean, which is enormous.
- 18:24And then we ran samples that were known
- 18:26to be positive for syphilis. And the
- 18:28first time we did that, we only got 65%
- 18:31correct. So, we said, "Okay, that's not
- 18:32good. Let's try that again." And then we
- 18:34got 80% correct.
- 18:36Um and then we did this other test
- 18:38called finger stick versus venous where
- 18:40we would actually collect samples from
- 18:42within Theranos, from our own from
- 18:44ourselves and from our co-workers. We
- 18:46would get the finger prick. We would get
- 18:48the venous draw. We would test them both
- 18:50and compare the results to make sure
- 18:51that, you know, you could actually do a
- 18:52finger prick for this.
- 18:54And a ton of us tested positive for
- 18:57syphilis.
- 19:00And I remember the manager of our lab
- 19:02just going,
- 19:03"Guys, it's not impossible."
- 19:08Uh I guess it's not impossible, but if
- 19:11it's plausible, then we should maybe
- 19:13send out like a company-wide email or
- 19:17something. But obviously, no one no one
- 19:19took that seriously. So, Yeah. Um that
- 19:22was a huge red flag.
- 19:23Um yeah, the syphilis test was
- 19:24definitely for me like the big the big
- 19:27kind of like wake-up call. Yeah.
- 19:29And after reporting these troubling
- 19:32results, um you voiced after recording
- 19:34these troubling results, both of you
- 19:35voiced your concerns, which led to
- 19:38threats of various sorts. Tyler, at your
- 19:40worst, it was reported you were followed
- 19:42by private investigators. You had
- 19:44lawyers showing up to your grandfather's
- 19:46house unannounced on what was a friendly
- 19:48visit. Erika, you had an individual
- 19:50follow you to your new workplace, um who
- 19:53even knew your temporary home address,
- 19:55which even your mom wasn't aware of.
- 19:57Um how did you handle
- 19:59that type of pressure, and how did you
- 20:01handle the threats um when you reported
- 20:03your concerns?
- 20:06Oh,
- 20:07I did a lot of running cuz I
- 20:09was so paranoid and freaked out. Um
- 20:12yeah, it was
- 20:14it was a really tough process. I hadn't
- 20:17expected them to quite go to that
- 20:19degree, so
- 20:20um
- 20:21essentially
- 20:23after we had reported, I had been
- 20:25getting calls from Theranos and had
- 20:27chose, "Okay, I'm not going to engage
- 20:28with these people because I don't owe
- 20:30them anything. There's no reason to
- 20:32engage with them." And And after that,
- 20:36uh they had showed up at my workplace.
- 20:38So, I was working late. My coworkers had
- 20:40come up to me and they said, "Erica,
- 20:42there's been someone who's been sitting
- 20:43outside all day. We don't feel
- 20:45comfortable for you to just go alone
- 20:47into your car. We're going to walk you
- 20:49to your car." And
- 20:51they walk me to my car. This man comes
- 20:53up to me and he hands me this letter,
- 20:55and I look at the letter and I see it,
- 20:57and it was for an address for a
- 20:59temporary home I was staying. I was in
- 21:00between houses, and so I was staying
- 21:02with my coworker Julia, and I was
- 21:05completely freaked out because no one
- 21:08had known this address. No one knew I
- 21:10was living in this place. I was
- 21:11technically only staying in this place
- 21:13Monday through Friday, and then every
- 21:14weekend I'd go to LA or and see my
- 21:17family and move stuff.
- 21:19Um and completely panicked. And actually
- 21:23uh
- 21:24it was a bit weird because Tyler and I
- 21:26were going through similar experiences,
- 21:28but actually had to silo from one
- 21:29another. And I had made up this cuz I
- 21:32thought I was being followed. Tyler, I
- 21:34think, was also being paranoid about he
- 21:36was followed. I
- 21:37had this lamp that I said I'd give him.
- 21:40So, I just like randomly had this lamp
- 21:42in my house and showed up at his house
- 21:44and pretended that the reason I was
- 21:46there was to give him this lamp. And
- 21:49then we went into this like backwood
- 21:50area to talk to each other to just check
- 21:52in and like, "What is going on?
- 21:55What is going on? Like, I am absolutely
- 21:57terrified right now. I don't feel
- 21:59comfortable talking to anyone. Like, at
- 22:02this point, you know, I think I'm I was
- 22:0323, right? I have no money to my name,
- 22:06thinking that I'm going to have to hire
- 22:07a lawyer, and not knowing how much
- 22:09that's going to cost me. Um and it and
- 22:12and I'm being followed, right? People
- 22:14are taking the extreme of of following
- 22:16me places, so Yeah, actually, I think
- 22:18Erica, we had like a an extra room, and
- 22:20Erica was supposed to stay in that extra
- 22:22room for a little while, and she said
- 22:23she could bring me a lamp because I had
- 22:24no light in my room.
- 22:26Um
- 22:27literally no light. Um and then I just
- 22:31started ignoring her. She would text me,
- 22:33she would message me on Facebook, and I
- 22:35just stopped talking to her hoping she
- 22:37would like get the hint or something.
- 22:39Which I did.
- 22:39But then I was actually in my driveway
- 22:41when I saw her driving down our into our
- 22:44driveway, and I remember thinking, "Oh,
- 22:45no."
- 22:47Um cuz we weren't I wasn't supposed to
- 22:49be talking to anyone from Theranos
- 22:51anymore.
- 22:52Um but then I obviously really wanted to
- 22:53talk to Erica, so I didn't send her
- 22:55away.
- 22:57Um
- 22:58but then I remember we went inside and I
- 23:00was like, "Uh actually, let's go back
- 23:01outside." And we went into this like
- 23:03random place. I was living out in Los
- 23:04Altos Hills, so we went like down into
- 23:07the bushes.
- 23:08Um
- 23:09because we knew someone was following
- 23:12us, and like I don't know. I was
- 23:15I don't know. We were just
- 23:17I had a burner phone for like over a
- 23:19year because I was scared my phone was
- 23:21being tapped. And maybe that was me
- 23:23being very, very paranoid, but that's
- 23:25again back to that statement of culture
- 23:27of fear.
- 23:28Um just the amount of secrecy, signing
- 23:32the NDAs, the retaliation of coming
- 23:34after employees.
- 23:36This is how paranoid a lot of us were.
- 23:39We like I Yeah, I had a a fake phone for
- 23:43over a year. And if I wanted to discuss
- 23:46anything, like I never said the word
- 23:48Theranos. It was like you know, the like
- 23:51forbidden word for a long time,
- 23:52especially in near any of my phone
- 23:54communication cuz I was I was so nervous
- 23:56about
- 23:58the potential consequences of what that
- 24:00that could have.
- 24:02I had a burner phone, too. Yeah.
- 24:06With all these threats, intimidation
- 24:09tactics, how did you still find the
- 24:11courage? Was there ever a thought of
- 24:13just remaining silent and just moving
- 24:15on, perhaps like some of the other
- 24:17employees at the company?
- 24:19Um well, I think at that point it was
- 24:22too late.
- 24:23You know, by the time we were getting
- 24:24kind of bullied around, it was the
- 24:26decision had been made.
- 24:27Um I at least had no idea what I was
- 24:30getting into when I got into it. Um
- 24:35I I I mean, I had no idea what was
- 24:37coming. Mhm.
- 24:39But once I was in it, there was I was
- 24:42there was no question in my mind that I
- 24:44was
- 24:45about being right. I knew I was right.
- 24:48Um
- 24:49there was I was not going to give in.
- 24:51There's no way. I was so stubborn. Yeah.
- 24:53There was no way I was going to say I
- 24:55was wrong when I knew I was right. No
- 24:56chance.
- 24:58Yeah. I had a different experience than
- 25:00Tyler. We're talking about this. Like, I
- 25:01really felt
- 25:03uh there's this term that I just learned
- 25:04called gaslighting, and it's where you
- 25:07make someone believe that they are the
- 25:09crazy one. And you use these different
- 25:11manipulation tactics to make someone
- 25:13believe that. And really at Theranos, I
- 25:16thought I was missing something, that I
- 25:18didn't have enough information, the fact
- 25:20that I was with people who were PhDs
- 25:21from MIT, that we had huge teams of
- 25:24people working on this project. We were
- 25:27almost like 200, 300 employees.
- 25:30Me being 22 and come fresh graduate out
- 25:34of college, like I just was missing
- 25:36something.
- 25:37And for me, it wasn't until I knew there
- 25:40was a lot of messed up things going on,
- 25:42and frankly, I'm just not one of those
- 25:43people who can kind of keep quiet. Like,
- 25:46I'm just going to tell you like, "Yeah,
- 25:47this is wrong. Like, I don't know what
- 25:48they're doing, but you know, this was my
- 25:50experience, and I'm
- 25:51uh for better or worse, very transparent
- 25:54uh about about information in general.
- 25:57Um but it was it wasn't until that type
- 26:00of retaliation that I knew
- 26:02"Okay,
- 26:04they're hiding something." You know, the
- 26:06fact that they're going to these types
- 26:07of lengths to come after me, again being
- 26:10a 22-year-old who's a fresh grad,
- 26:13um there's something going on here.
- 26:15Like, I you know, they're lying to
- 26:18patients. And honestly, because they'd
- 26:20come after me and I had to seek the help
- 26:23of a lawyer, I was able to have a
- 26:25conversation with them about "How do I
- 26:27report this to a regulatory agency? What
- 26:29does it mean to be a whistleblower? What
- 26:31are the next steps to make sure that
- 26:33they stop processing patient samples?"
- 26:35Because
- 26:36you know, at this point I know and I'm
- 26:38certain that they're trying to cover
- 26:39something up.
- 26:41Um
- 26:42and so in in a weird way, it kind of
- 26:45backfired on me that they retaliated.
- 26:46But then it gave it empowered me with
- 26:49the information I needed to know to say
- 26:52"I know how I can tell CLIA everything
- 26:53they need to know
- 26:55to where they can do this inspection and
- 26:57actually find out are they
- 27:01um testing patients the way that's
- 27:03appropriate?" And come to find out it
- 27:05wasn't, and and CLIA shut them down,
- 27:07which was
- 27:08um
- 27:09ultimately what I wanted in the end. I
- 27:11wanted them not to let let not have them
- 27:14lie to patients anymore.
- 27:16Yeah.
- 27:17On the note of intense retaliation, my
- 27:19next question is for you specifically,
- 27:21Tyler. The Wall Street Journal reported
- 27:23that you'd incurred over $400,000
- 27:26in legal fees, and that your parents
- 27:28almost had to sell their house to defend
- 27:30you. Um your grandfather was also on the
- 27:33board of Theranos. How did you handle
- 27:36this type of pressure, especially
- 27:37knowing that family was involved?
- 27:40Um I mean, it definitely was not easy.
- 27:44So, at at that time
- 27:47uh I mean, my lawyers told me that the
- 27:50only people I can talk to you are my
- 27:51wife,
- 27:52my lawyers, and my priest. And I'm not
- 27:55religious, and I'm not married.
- 27:59So, the only person I can talk to you
- 28:02are my lawyers, and that is an extremely
- 28:05expensive therapy session.
- 28:08I wasn't talking to anybody, um and it
- 28:10was really weird for me to be
- 28:11disconnected from my parents. You know,
- 28:12my parents obviously knew crazy things
- 28:14were happening, but they didn't know
- 28:15what the details were.
- 28:17Um but the only source of information
- 28:19that they were getting was actually from
- 28:21my grandfather, which is ultimately um
- 28:23he was kind of like a a microphone for
- 28:25Elizabeth. So, Elizabeth could talk to
- 28:27my parents, but I couldn't talk to my
- 28:28parents. It was kind of how it seemed.
- 28:30Um
- 28:31so, they were kind of under the
- 28:32impression that I was being I was the
- 28:34crazy one. They were told that 80% of
- 28:37what the Wall Street Journal came only
- 28:38from me.
- 28:39Um that I was being unreasonable in our
- 28:42negotiations to try to settle things.
- 28:44Um so, we had a tough conversation where
- 28:47they said, you know,
- 28:48"The next opportunity you have to sign
- 28:50something, just sign it um and end this.
- 28:53This is not your fight anymore. You've
- 28:54done enough."
- 28:56Um
- 28:57and you know, they said, "We will
- 28:59support you no matter what, and we will
- 29:01sell our house to keep paying for your
- 29:02legal fees, but please just end it."
- 29:06Um but I didn't do that. I let it keep
- 29:08going, racked up a huge
- 29:11a huge bill, but um my parents were
- 29:13awesome the entire time. Luckily, it
- 29:15ended
- 29:17luckily, they stopped bothering me
- 29:18before it came to the point where they
- 29:20had to sell their house.
- 29:21Um but yeah, it was a huge huge bill at
- 29:25the end of the day, but it's funny cuz
- 29:27for me
- 29:28um
- 29:29it ended up being I kind of saw money as
- 29:32like runway. I had really no emotional
- 29:35attachment to it. I saw it as like,
- 29:37"Okay, I can put up a fight for this
- 29:39long, so
- 29:41I need to, you know, figure out ex- be
- 29:43No, obviously be um
- 29:46be smart, but um
- 29:49you know
- 29:50fight This is how long I can I can put
- 29:51up a fight. I didn't have like an
- 29:53emotional attachment to oh no, I'm
- 29:54losing hundreds of thousands of dollars
- 29:56as this goes on.
- 29:58Um and I think that just goes back to
- 30:00how stubborn I was and how
- 30:02how convicted I was in in knowing that I
- 30:05was right.
- 30:08Sure. I would like to reflect now more
- 30:11on the board of Theranos. The board of
- 30:13Theranos
- 30:14um included secretaries of state,
- 30:16secretaries of defense, generals, a lot
- 30:19of other big names and influential
- 30:21people.
- 30:22Would you say that these individuals,
- 30:24would you hold them guilty or culpable
- 30:25in any way? Or would you feel they were
- 30:27totally unaware, just placeholders,
- 30:30really?
- 30:34I mean,
- 30:36it's one of those things when you come
- 30:37in as an investor
- 30:39um I I guess this is a good warning sign
- 30:43to investors, hey, do your due
- 30:45diligence, right? If you don't know
- 30:47anything about medical diagnostics,
- 30:49maybe you should bring someone in to
- 30:51kind of research what the product is and
- 30:54the people behind it and and what's kind
- 30:56of going on here.
- 30:57I think in the case of Theranos and what
- 30:59we saw by the SE SEC filings and
- 31:02everything, they were feeding their
- 31:03investors a lot of false information.
- 31:06So, how would an you know, the board of
- 31:08directors members know what the extent
- 31:11of which was going on if
- 31:14you know, Sun-
- 31:15Sunny and Elizabeth were lying to their
- 31:18board members about what was happening.
- 31:20Um I think they strategically decided to
- 31:22choose board members that didn't have a
- 31:24medical background, that didn't have a
- 31:26biotechnology background, so they were
- 31:28able to
- 31:30um
- 31:31not have people that would investigate
- 31:32very deeply in kind of the technology
- 31:34and what was going on.
- 31:36Um whether they should be held
- 31:38accountable or not, it's it's hard to
- 31:40say, right? Cuz you don't know what
- 31:41those conversations were. I I highly
- 31:44doubt uh all of these people would have
- 31:48invested in this company and continued
- 31:51um their commitment to the company,
- 31:53which many of them didn't, you know, as
- 31:56as more information was getting exposed
- 31:59if they had known what was actually
- 32:00going on.
- 32:04Yeah. Yeah, it's hard to know. I mean, I
- 32:06think the board the board was negligent
- 32:08at best.
- 32:10So, I think there is some responsibility
- 32:12there and I think anytime you give
- 32:13someone a check for over a hundred
- 32:14million dollars, you are giving that
- 32:15person an incredible amount of power
- 32:18and you should
- 32:20you should do more due diligence, I
- 32:22think. There was a
- 32:23a complete lack of due diligence that is
- 32:25just astounding. Yeah.
- 32:27And we were talking about this, like it
- 32:29was kind of like an echo chamber, where
- 32:31it's like you get that one guy that you
- 32:32have a lot of respect for who then gets
- 32:34like one other guy who they have a lot
- 32:36of respect for and then you have, you
- 32:38know, Elizabeth basically convincing
- 32:40both of them that they're great and then
- 32:42they're telling each other how great
- 32:44Elizabeth is, but it's all fed from the
- 32:46information of this one person and then
- 32:48it just kind of Yeah. gets it echoes
- 32:52around And then even if you do bring in,
- 32:54you know, one more person, it's like,
- 32:56okay, you you expect this one person to
- 32:58tell secretaries of state, defense
- 33:01that they're all wrong.
- 33:03No, yeah, it's not going to happen.
- 33:06Especially if you I mean, yeah, if
- 33:08they're like your friend or whatever.
- 33:10Yeah. Like
- 33:12Henry Kissinger brought in this surgeon
- 33:14from New York who he says is the
- 33:16smartest man in the world. So, obviously
- 33:17they're good friends.
- 33:19Um of course he's just going to like I
- 33:21don't
- 33:22apparently he like did due diligence or
- 33:24whatever and said it was all good, but
- 33:26you know, I don't know. But how honest
- 33:28is he really going to be with all these
- 33:30people?
- 33:33I'd like to explore the theme of
- 33:35accountability a bit more, especially
- 33:36with the employees now. Many employees
- 33:38at Theranos stayed silent despite
- 33:40knowing that the claims made in the
- 33:42media were obviously false and knowing
- 33:45that patients were at risk. On their
- 33:46perspective, they were arguably silenced
- 33:49by intense pressure from Theranos,
- 33:51including the threat of heavy
- 33:53litigation, intimidation tactics as as
- 33:55you've already mentioned. Would you hold
- 33:57your fellow employees who stayed silent
- 33:59culpable or guilty in any way?
- 34:03That's super hard, right? I definitely
- 34:05do not. Yeah, I don't either, but
- 34:08Um
- 34:10I mean, it was a really tough situation.
- 34:12Um like if I could go back and give
- 34:14myself my advice, I would probably tell
- 34:16myself not to do anything. Like that
- 34:18would be my advice, like
- 34:20you're going to pay a huge huge price
- 34:22for this. Someone will figure it out
- 34:23anyway, don't do it.
- 34:25Knowing myself, I would have ignored
- 34:27that advice and done it anyway, but
- 34:30Um but I I don't think any less of my
- 34:34co-workers who didn't do what I did.
- 34:38Yeah, it's really complicated, right?
- 34:40Because these people, again, they have
- 34:41families, they have
- 34:45Okay, there there are several different
- 34:46things. So, Theranos was a big
- 34:47organization. So, if you're a software
- 34:49developer just doing the interface for
- 34:51how the machines work, you're not really
- 34:53going to know what's going on with the
- 34:55patient processing. So, there are a lot
- 34:57of employees that were just very
- 34:59ignorant to what was actually going on.
- 35:02One, because of the way that the
- 35:03structure of the company was worked,
- 35:05there were physical barriers blocking
- 35:07people. There was card key access where
- 35:09some people couldn't get in and others
- 35:11could.
- 35:12Um
- 35:13So, so it makes it really hard for a lot
- 35:16of even the internal employees going
- 35:19like within the company to know what's
- 35:20going on. And then the people working in
- 35:24a clinical setting, like an example is
- 35:26we had clinical lab scientists that
- 35:28typically would work in hospitals, they
- 35:30do all the patient processing. For us in
- 35:32the clinical lab, a clinical lab
- 35:34scientist could not see what was going
- 35:37on with the Edisons and the Theranos
- 35:39proprietary devices until they could be
- 35:41trusted. So, we had CLSs that were on
- 35:44board, but they were stuck in a separate
- 35:47room and not to see the actual machines
- 35:49that we were using to test the patients.
- 35:51So, there were definitely a lot of
- 35:53processes like this that like the own
- 35:56staff and employees were guarded from
- 35:58seeing what's going on.
- 36:00Um you know, even in my case, I didn't
- 36:03end up reporting to the Center of
- 36:05Medicaid and Medicare Services until I
- 36:06talked to a lawyer. Like never in my
- 36:09life would I have anticipated that I was
- 36:11going to have to report a company to a
- 36:13regulatory agency. There is nothing in
- 36:16life that prepares you for that
- 36:17experience at all. There's just like no
- 36:20school class, nothing. No one
- 36:22anticipates having to do this.
- 36:24Um and so even that first step of
- 36:27engagement is really hard to figure out.
- 36:29Like for me, I
- 36:31how how do you find the number to for
- 36:34the Center of Medicaid and Medicare
- 36:36Services with the specific domain of lab
- 36:40diagnostics, right? Like just even
- 36:42finding that phone number is actually
- 36:43quite hard. Um
- 36:46So, it it's it's it's one of those
- 36:48things that, you know, no one is really
- 36:49prepared for these types of instances of
- 36:52of of what to do and it really took, I
- 36:55think, the specific
- 36:57experiences that, you know, I had at
- 36:59least I can speak for myself
- 37:01um to know what to do and that empowered
- 37:03me to sort of make the decision to to
- 37:05come forward.
- 37:09I'd now like to move on to a broader
- 37:11reflection, I guess, of Silicon Valley
- 37:13on the whole. Now, many people associate
- 37:15Silicon Valley, of course, with um
- 37:18limitless innovation
- 37:20pioneering novel technology, but there
- 37:21has been pushback against its reckless
- 37:23culture. Vaporware, the public marketing
- 37:26of technology that is yet to be fully
- 37:28realized, is perhaps the worst result of
- 37:30this.
- 37:31Um so, do you think there is a broader
- 37:33problem with Silicon Valley culture, of
- 37:35which Theranos and Facebook are just
- 37:37symptoms of?
- 37:39Mhm.
- 37:40Um so, after Theranos, I actually
- 37:42started my own company and I was part of
- 37:43the the Stanford StartX incubator.
- 37:47And overall, I would say, you know,
- 37:49almost every single person in there is
- 37:51just a really passionate person and
- 37:55they're not I mean, I don't think anyone
- 37:57in that incubator, at least, is selling
- 37:59vaporware.
- 38:00Um
- 38:01So, in my experience, I would say no, I
- 38:04don't I don't I don't think it's a
- 38:06it's a huge problem. I I genuinely think
- 38:08that most entrepreneurs are just really
- 38:10passionate, smart people.
- 38:12Yeah.
- 38:13I think the problem here isn't
- 38:15necessarily saying, okay, I want to
- 38:17build this product, I need capital do
- 38:19that and you know, this is my idea and
- 38:24this is like the
- 38:25the, you know, minimal viable product
- 38:28that I have and here are my plans, can
- 38:29you give me the capital to sort of build
- 38:31this? Right? And that's that's very
- 38:33normal. That process is very normal. I
- 38:34think the like greater problem here is
- 38:37is
- 38:38uh lying and and sort of being
- 38:40delusional. And this this happens across
- 38:42the board. You know, in the case like
- 38:46you know, not disclosing to someone uh
- 38:49not disclosing to your investors that
- 38:52you know, I am launching a product
- 38:55that's not ready on patients. Like that
- 38:58that's a problem, right? Like that's a
- 39:00that's a severe problem. Um
- 39:05I
- 39:05think
- 39:07it's hard to say, like we were talking
- 39:08about the software model. So, in
- 39:10software, you have this instance where
- 39:12you iterate constantly. Like what makes
- 39:15a good technology product is the fact
- 39:16that you can, you know, kind of throw
- 39:19something out there, see how people
- 39:21respond, based on what the better
- 39:23response rate is, you curtail to the
- 39:25next thing. And I think at Theranos,
- 39:28they were trying to take the same
- 39:29software model, but with medical
- 39:32diagnostics. And you can't do that,
- 39:34right? You can't decide, okay, I'm going
- 39:36to launch this product, sacrifice six
- 39:38patients,
- 39:40uh you know, see if like some responded
- 39:42well, then I can move, you know, in this
- 39:46other direction to sort of iterate and
- 39:47improve on these medical diagnostics.
- 39:49It's just really it's it's a different
- 39:51industry, it's a different field, and
- 39:52it's not something that, you know, you
- 39:54can just test on a few users here and
- 39:56then kind of change what the the the the
- 39:59product looks like. It's it's it's a
- 40:01very different, um,
- 40:04it's a just a very different industry.
- 40:05You just can't do that in health care.
- 40:08Do you think that there should be any
- 40:10alternative cultures that should try to
- 40:11be fostered, or would you or do you
- 40:13believe that it's fine to segregate,
- 40:15keep software as it is, or would you
- 40:16want to
- 40:17hope to do any you would you hope for
- 40:20any alternative culture and hope that
- 40:22that would maybe inspire the other
- 40:25industries to have to be less reckless,
- 40:27perhaps? Yeah,
- 40:28just be honest, you know? Just be
- 40:30honest, just be transparent. Uh,
- 40:35be transparent and honest with your
- 40:36customers and with your investors, and
- 40:39just say like, "Look, this is where
- 40:40we're at." Uh, and you know, these are
- 40:43be passionate still about what the
- 40:45possibilities of them some things are,
- 40:47but be realistic in like what can
- 40:50actually be reality versus
- 40:53Yeah, got to be clear about what is
- 40:54vision. Yeah.
- 40:56What's the vision and what is reality?
- 40:58Exactly. Um,
- 41:01yeah.
- 41:01Yeah, entrepreneurs are definitely
- 41:02responsible for selling the vision, so
- 41:06I guess sometimes it's easy to get like
- 41:07too caught up in selling your vision you
- 41:10start pretending like it's real. Yeah.
- 41:12But
- 41:13I think I don't think it happens.
- 41:16I don't know. In my experience, I
- 41:17haven't seen that happen too too often.
- 41:20Uh, I see it a lot. Uh, I'm on the I see
- 41:23it all the time. Especially, yeah, I see
- 41:26it all the time. In Hong Kong, ICOs have
- 41:28been very big, and just watching people
- 41:31uh, now raise money in a very
- 41:34unregulated way, I've seen people say,
- 41:36"Oh, yeah, I have this great like
- 41:38electronic medical records system, you
- 41:40know, it's going to leverage AI to be
- 41:42able to do pre-predictive diagnostics."
- 41:44And you ask them the simple question,
- 41:46"Hey, let me Can I see your product? Can
- 41:48I see a product demo?" And it's a Google
- 41:49Form. Like that's all it is, and you're
- 41:51like,
- 41:52But they still showed you the Google
- 41:53Form.
- 41:53They still showed me, yeah. Yeah. It's
- 41:56like, "Look, you can input your name."
- 41:58I'm like, "Oh, great."
- 42:02Um,
- 42:03Elizabeth would have said proprietary.
- 42:05Proprietary, yeah, exactly. That was
- 42:07that was the scope proprietary. Sorry, I
- 42:09cannot disclose this. Um,
- 42:12yeah, I I I think now coming from an
- 42:15investment perspective is like just be
- 42:16honest, just be transparent. Like people
- 42:19want these things to succeed, especially
- 42:21the vision like Theranos, right? Making
- 42:24diagnostics
- 42:26cheaper to produce, more affordable. You
- 42:28wouldn't even need insurance to be able
- 42:30to get these tests done. Like who
- 42:32wouldn't want to support a project like
- 42:34that? If you're honest with me and tell
- 42:36me like, "Look, this is our vision, this
- 42:38is what we want to do, this is where
- 42:39we're at, you know, we anticipate, you
- 42:42know, we need to hit these milestones by
- 42:43this point, you know, this is our plan,
- 42:45this is our strategy." I'm more than
- 42:47willing to give you cash. Many investors
- 42:50are more than willing to give you cash
- 42:52in order to
- 42:54have that come into fruition.
- 42:56But don't don't lie about it. Don't
- 43:01falsify data. Don't, um, falsify how
- 43:04much revenue you're making. All these
- 43:06things, it's like really just just being
- 43:09honest. It's such a simple thing. It's
- 43:11it's almost hard to say that we that's
- 43:14an alternative culture.
- 43:16Um, you know,
- 43:17uh,
- 43:18yeah.
- 43:20On those values of honesty and
- 43:23transparency, um, what do you think
- 43:25should be the role of educational
- 43:26institutions such as here at Stanford in
- 43:28preparing young graduates to navigate
- 43:31ethical challenges in their careers?
- 43:36You got anyone with this one? Um, I
- 43:39don't know. I think it'd be really
- 43:40really tough. I don't think I could have
- 43:41taken a class that prepared me for this.
- 43:44Yeah. Um, I think it's in probably most
- 43:47important to just be introspective about
- 43:49the
- 43:50about your own experiences. Like
- 43:53after this happened to me, I've had tons
- 43:55of people come tell me that say, "Oh,
- 43:57I've experienced something very similar,
- 43:59obviously not on the same magnitude, but
- 44:02very similar situation." Like so many
- 44:04people have said that, and I think
- 44:05probably everyone in this room has an
- 44:07experience that's somewhat similar and
- 44:08they can relate, at least to some
- 44:10degree. So, I think even better than a
- 44:12class is just to like
- 44:14be aware when these types of situations
- 44:16happen and
- 44:17check in with yourself and see like what
- 44:19did you do, what maybe
- 44:21should you have not done, or what could
- 44:22you have done better, and, um,
- 44:25yeah, I don't know.
- 44:26But I think it'd be
- 44:27hard to have a class that prepares you.
- 44:30Yeah.
- 44:30Um, but I think it would be good to know
- 44:32that like whistleblower laws exist.
- 44:36Cuz I didn't know that at all.
- 44:38Yeah. Um, yeah. If you go down the right
- 44:41channels, you actually have a lot of
- 44:42protections as a whistleblower.
- 44:45So, it's good to know those channels.
- 44:48Yeah, I I I after this all happened,
- 44:50I've been getting a lot of feedback from
- 44:52people that say the same thing, whether
- 44:53you work for the NHS, or whether you're
- 44:56in academia, or you're working for a
- 44:58biotech company, a lot of people are
- 45:00like, "Hey, I'm seeing kind of shady
- 45:02stuff going on in my workplace, and, you
- 45:06know, I I want to do something about it,
- 45:08but I don't know what to do about it."
- 45:10Um,
- 45:11and, you know,
- 45:13I I feel bad because people feel that it
- 45:16cuz I was in that position, I will know
- 45:17what to do, but I have no idea how you
- 45:19would report, you know, something to the
- 45:21NHS or anything, uh,
- 45:24even in academia, I don't know how to go
- 45:26through that process. I think we're at
- 45:28an interesting time where, you know, I
- 45:30we were talking about this with Theranos
- 45:32in and in my case, like I had a lot of
- 45:36doubts whether, you know, what was going
- 45:39on was again
- 45:42uh, like I had a lot of doubts about my
- 45:43own knowledge about the regulatory
- 45:45landscape. But what I was able to do do
- 45:47was go on the internet, stay up at 3:00
- 45:49in the morning, and like, "No, this is
- 45:51this is not the law. They keep telling
- 45:52me that this is the law, but it's not."
- 45:54Um, so I think for a lot of people
- 45:56knowing that, you know, there's a lot of
- 45:59resources that you can access. If you
- 46:00have a question, you can go on the
- 46:02internet. You can potentially talk to
- 46:04free lawyers. You can go and talk to
- 46:08people about certain concerns that you
- 46:10have, and they'll probably be able to
- 46:11tell you what the next steps are. Um,
- 46:14and if you're
- 46:16I you know, another big thing is if
- 46:17you're getting retaliation from people,
- 46:20uh, you know, learning how to have the
- 46:22mental fortitude to be resilient is
- 46:24really really important. Um,
- 46:28and to kind of,
- 46:30you know, s- stick to integrity, you
- 46:33know, saying to yourself like for me it
- 46:36was like I made the commitment by going
- 46:38into health care to make sure that I
- 46:41protected the patients that I served.
- 46:43And holding on to that simple line and
- 46:45that simple fact really carried forward
- 46:48all of my actions. Like this is this is
- 46:51the commitment that you made by going
- 46:52into this industry that you needed to
- 46:54protect patients. Um, I don't yeah, it's
- 46:57hard to formulate like a class or
- 46:59anything, but depending on what side
- 47:02you're coming from, like know you have
- 47:03access to resources now. We live in a
- 47:05beautiful time where you can type
- 47:07anything in, you know, to a search
- 47:09engine to figure out the right person to
- 47:10talk to or the right resources to go to.
- 47:14Um, if you are getting retaliation from
- 47:16your employees, just like
- 47:18take a moment, breathe,
- 47:20try and stay resilient through the
- 47:21process, and, um,
- 47:24um, I think those are the two two
- 47:27biggest things that I learned.
- 47:29How you can put that in a class, I don't
- 47:31know, but
- 47:32yeah.
- 47:33Honestly, having discussions like this
- 47:36is probably very valuable, too. Because
- 47:38many,
- 47:39you know, especially with technology in
- 47:41general,
- 47:43um, whether it's big data and AI,
- 47:45synthetic biology and genetic
- 47:47engineering, we're going to have a lot
- 47:49of these discussions kind of coming up
- 47:50where we don't know how to handle new
- 47:52technologies anymore. It's something
- 47:54that we haven't experienced, and we
- 47:56don't know the consequences necessarily
- 47:58of what they'll have when they get
- 48:01implemented into societies.
- 48:04So.
- 48:05What advice would you have for students
- 48:07or new graduates when looking at
- 48:08potential job offers, internship of
- 48:11offers to gauge for integrity and
- 48:13ethical environments? Both of you
- 48:15mentioned you had multiple job offers.
- 48:17Do you think there's certain questions
- 48:18you would have asked retrospectively, or
- 48:20any red flags you wish you had noticed
- 48:22perhaps in an interview setting?
- 48:24Uh, in retrospect, I would I would never
- 48:27work for another stealth company again.
- 48:30There's just no way I could
- 48:32There's no way I would step back into a
- 48:34stealth company, you know.
- 48:36I mean, that might be swinging too far,
- 48:37but I'm sure there are plenty of stealth
- 48:38companies that are fine, but like at
- 48:40least just me personally, like I want to
- 48:41be able to go
- 48:43do a job and then be able to tell my
- 48:45friends and family what I'm doing.
- 48:48Yeah. Having to sign an NDA before you
- 48:51go into a job interview is probably
- 48:53like, "Hmm, okay. What This is just a
- 48:56job interview. I haven't started working
- 48:57for you. What's going on here?" Um, I
- 49:00think just like with anything, just ask
- 49:03questions, do your due diligence. Like
- 49:05what I've realized with working is like
- 49:07you're going to spend at least 40 hours
- 49:09a week doing this thing.
- 49:12More likely more cuz you drive and you
- 49:13get there. Like asking people a lot of
- 49:15questions on, you know, what are your
- 49:17values? If people have left the company,
- 49:20talking to previous employees, what was
- 49:22their experience? I think alone at
- 49:24Theranos, if we had just talked to
- 49:25previous employees, that would have like
- 49:28set the record straight. Yeah, it would
- 49:30have really set the record straight
- 49:31quite fast. We would have realized like
- 49:34just the horrible horrible experiences
- 49:36that so many people had that preceded
- 49:39us. Yeah. Actually, a good question
- 49:40would be uh like how many people have
- 49:42quit in the last Yeah.
- 49:444 months.
- 49:49If it's like 20% of your company
- 49:51Yeah.
- 49:52And probably if they say the other issue
- 49:55too with us at like anytime you would
- 49:57ask uh Elizabeth a question, it would
- 50:00always be, "I'm sorry, I can't disclose
- 50:01that. That's confidential information."
- 50:03So, that's probably another thing where
- 50:05you're like, "Hmm, okay." Like is this
- 50:08warranted secrecy or not? Um
- 50:11but
- 50:13it's it's Yeah, just do your due
- 50:15diligence. Ask a lot of questions. Talk
- 50:17to former employees. That would have
- 50:19probably been the most illuminating is
- 50:21just to talk to former employees.
- 50:23On the other turn, as a startup founder,
- 50:25this my next question is sourced from a
- 50:27member of the audience. Um
- 50:29how should young startup for founders
- 50:31work to establish integrity and an
- 50:34ethical environment, especially in
- 50:36fields like healthcare?
- 50:40Um
- 50:41Just be honest.
- 50:42Yeah.
- 50:44I think it just it's going to take a
- 50:45long time. Yeah. Um so, start building a
- 50:48track record as early as you can.
- 50:50I read a a good article actually with
- 50:53the Stanford um business school. They
- 50:56were talking about
- 50:57how in business you tend to create
- 51:01metrics for your shareholders. So,
- 51:04you're constantly focused on things like
- 51:06ROI, and maybe it's much better if we
- 51:09start thinking about who are our actual
- 51:11stakeholders. So, in the case of, you
- 51:13know, uh a healthcare, like what are the
- 51:16things that would make this product or
- 51:18service successful for my patients? And
- 51:20really examining the business in a more
- 51:23holistic way where we're you know, maybe
- 51:26we need to design the way that we
- 51:28examine a company not solely by the
- 51:30revenue it's generating and the profits
- 51:32it's making, but also about what are its
- 51:34consequences for society. What are its
- 51:37consequences for, you know, the
- 51:39hospitals it serve, the patients it
- 51:40serves, the
- 51:42potentially even the insurance providers
- 51:45that it has. Um and
- 51:48to
- 51:50you know, not solely focus on the bottom
- 51:53line.
- 51:56And my final question, um I would like
- 51:58to hear more about where your careers
- 51:59are now and how this whole experience of
- 52:01being a whistleblower has impacted your
- 52:04careers. Has it Do people view it
- 52:06favorably? Are there Is anyone you've
- 52:07interacted with who views your tag as a
- 52:09whistleblower cautiously? I'd love to
- 52:11hear about the reflections on your life
- 52:13after this experience.
- 52:17Uh for me, it's only been positive.
- 52:19Yeah.
- 52:20Um and it's kind of weird cuz in I think
- 52:22in most whistleblower situations, the
- 52:24whistleblower has a really hard time
- 52:25kind of getting their life back on
- 52:26track. But for me, it was like the exact
- 52:29opposite. Like after the Wall Street
- 52:31Journal article
- 52:32um like said who I was, I was getting
- 52:35job offers from venture capital firms
- 52:38from big biotech companies, from small
- 52:40startups, from research institutions.
- 52:43Like really the whole gamut. I was
- 52:44getting emails of people saying, "Hey,
- 52:47love what you did. Come work for us."
- 52:48Yeah. And I think that's actually really
- 52:51rare in these types of situations, and I
- 52:52honestly don't know what's different
- 52:54about my situation than other
- 52:57whistleblowers. Yeah.
- 52:59I had a similar It was overall it was
- 53:01very very positive. I think the thing
- 53:04you never know and Tyler, I think you
- 53:05actually said this to me. You never No
- 53:07one who has a problem with it or who
- 53:10thinks it's a bad thing will tell you.
- 53:12So, you really don't know what the
- 53:14consequences of it are going to be until
- 53:18you're in a room with a VC and then they
- 53:20get confronted by, you know, they would
- 53:22say say, "Oh, you were the whistleblower
- 53:23of Theranos. Okay, get out of my room."
- 53:25potentially. I don't know cuz you really
- 53:27can't predict when that would happen,
- 53:29but I feel like the people that had a
- 53:31problem with it are not going to tell
- 53:33you. The people, of course, who
- 53:35you know, admire what you did, that
- 53:37they'll be very communicative about
- 53:39about that process.
- 53:41Um it's been really interesting now. So,
- 53:44since I left Theranos, I I now work for
- 53:46a tech accelerator in Hong Kong. So, we
- 53:48invest in early stage startup companies.
- 53:50And now going outside of working for a
- 53:54startup, building the product, knowing
- 53:56the grind and the hustle of like, "How
- 53:58do I get this thing to work? How do I
- 54:00get people to actually want what I'm
- 54:02making?" Um and now sitting on how do I
- 54:06evaluate a company and um
- 54:09it it
- 54:10you know, is this a good investment or
- 54:12not? Uh it's
- 54:14made me much more skeptical with those
- 54:17investment decisions. Like it's just the
- 54:19simple thing of just asking people for a
- 54:21product demo. You would think it would
- 54:23be the like first thing you would want
- 54:25to see, but so many investors fail to do
- 54:27that, to actually just sit and dig into
- 54:29the product. Um yeah, this is definitely
- 54:33you know, kind of
- 54:34made me, I think, a much better investor
- 54:37and doing much more
- 54:38uh much
- 54:40better due diligence on the companies
- 54:42now that we support. Um
- 54:44I'm hoping that
- 54:47this won't hurt my career in the future,
- 54:49but honestly, you you don't know kind of
- 54:52when something will come back to bite
- 54:53you until it does. I have one kind of
- 54:56funny anecdote. So, I was asked to uh
- 54:58like call into a a business school class
- 55:00at Yale.
- 55:02Um so, I did that, but the professor
- 55:03didn't announce to the class that I was
- 55:05on the line yet. And he asked, "Does
- 55:07anyone think that Tyler Shultz did the
- 55:08wrong thing?" One person raised their
- 55:10hand, and he called on her, and and she
- 55:13he said,
- 55:14"He's on the phone right now. Do you
- 55:15want to tell him why?"
- 55:18And she went,
- 55:19"No."
- 55:20I'm like, "Come on. Trust me, I can take
- 55:22it."
- 55:24But I think she didn't speak up. Yeah.
- 55:26But there are people out there.
- 55:28Yeah.
- 55:29Um it's been incredibly inspiring to
- 55:31hear from both of you, and I'd like to
- 55:33thank you on behalf of the Stanford
- 55:34community for being so candid and
- 55:36sharing your insights. Um I think
- 55:38students can certainly look up to you as
- 55:39role models on how to stay true to your
- 55:42core values even under intense
- 55:44adversity. Um it's been my deep pleasure
- 55:46to moderate this discussion. For the
- 55:48next segment, I'd like to invite Colin,
- 55:50who will moderate a Q&A uh from the
- 55:52audience now.
- 56:07So, why don't we start with the
- 56:08gentleman with the Yale shirt on right
- 56:10here?
- 56:12Um
- 56:13Is this on? Yeah, cool.
- 56:15Uh well, first um you you guys made
- 56:17enormous sacrifices and and showed
- 56:19incredible bravery. So, thank you for
- 56:21that um first of all.
- 56:23Uh
- 56:24and and secondly, you know, so I read
- 56:26Bad Blood, and one of the things that
- 56:28I've been trying to wrap my head around
- 56:29that I still don't quite understand is
- 56:31just the psychology of it. You know, and
- 56:33I mean, obviously, you you guys aren't
- 56:34psychic uh Elizabeth's and and Sunny's
- 56:37head. But can can you help me understand
- 56:39like what the deal is with Sunny
- 56:40Balwani? Cuz it's like, you know, he
- 56:42sort of lurks he sort of lurks in this
- 56:44Bad Blood story, and it's never really
- 56:46clear, you know, is he like the puppet
- 56:47master behind the scenes or like, you
- 56:49know, Carreyrou came and gave a talk
- 56:50here, and you know, he sort of said he's
- 56:51this, you know, oblivious guy, whatever.
- 56:53Like and I I don't know. That didn't
- 56:55quite make sense to me. I'm just trying
- 56:56to to figure it out and wrap my head
- 56:58around it. It's this weird, dark,
- 57:00fascinating story that doesn't quite
- 57:02make sense. And so, I would love to sort
- 57:04of hear your guys' thoughts on that.
- 57:07Uh so, I would say that Sunny Balwani
- 57:10has the personality of gravel.
- 57:12It's like this
- 57:14grumbly
- 57:16I don't know. Grumbly guy just like very
- 57:18rough around the edges.
- 57:21Um I didn't interact with him all that
- 57:23much.
- 57:24Um but probably the most pleasant
- 57:27conversation I ever had with him was he
- 57:28was telling me about how he knows a lot
- 57:30of cops and they tell him when they're
- 57:31not patrolling 280 so he can go drive
- 57:33his cars really fast.
- 57:36Um but other than like I really didn't
- 57:37interact with him all that much, but he
- 57:39would like walk through the labs at 3:00
- 57:41in the morning and, you know, not really
- 57:44say anything. Just walk through and walk
- 57:46back out.
- 57:47Yeah. Um
- 57:49but he was definitely running the show
- 57:52inside Theranos, for sure.
- 57:55Yeah, it
- 57:57There were so many instances with him.
- 57:59It it was funny. Someone asked me the
- 58:01question, so
- 58:02like, "What did you think about him?"
- 58:04And it was clear I was trying to be very
- 58:07diplomatic about it. He's like, "Was he
- 58:09an [ __ ] or was he not an asshole?" I
- 58:10was like, "Total asshole."
- 58:12It's like hands down.
- 58:13Um
- 58:15but
- 58:17yeah, he definitely was running the show
- 58:18with a lot of the things that were going
- 58:20on. And even we did this internal
- 58:23proficiency testing. So, proficiency
- 58:25testing is where you're essentially
- 58:27trying to check if the results you are
- 58:29given in third-party labs,
- 58:32uh are you getting within the same
- 58:33accuracy range? And we had decided to um
- 58:40essentially test it on our old machines,
- 58:43like the Siemens Advia, all the other
- 58:45machines.
- 58:46Uh and the Theranos proprietary methods
- 58:49cuz what they used to do it on was just
- 58:51the old machines, and we were finding
- 58:53that the results weren't lining up. And
- 58:56he sent back First of all, he wasn't
- 58:58even on this email.
- 58:59So, he just got all of our emails, and
- 59:01we had no idea. He was like monitoring
- 59:03all of us.
- 59:04And piped in about how this was the most
- 59:07terrible thing that we had ever done.
- 59:09Like how dare we use the Theranos
- 59:11proprietary like the Edisons to
- 59:14double-check whether, you know, the
- 59:16results were actually accurate. It was
- 59:19all in broken English. Like you couldn't
- 59:20understand what he was saying. It was
- 59:22just an absolute mess.
- 59:24Um
- 59:25it was like he
- 59:28uh uh
- 59:29just
- 59:30was constantly surveillancing all the
- 59:32employees, was making a lot of calls and
- 59:34decisions without having the expertise
- 59:36within those domains, particularly
- 59:38within healthcare and a clinical
- 59:40laboratory. People had those like dots
- 59:44that they'd put over the cameras on
- 59:45their computers cuz they thought Sunny
- 59:47was watching them. And same with phone
- 59:49calls. Like everyone knew that their
- 59:50phone calls were being tapped and so
- 59:53people would like pass like I remember
- 59:55our lab director was so paranoid about
- 59:57it. He would like pass me notes
- 59:59because he was like convinced that they
- 1:00:01were monitoring all his phone calls.
- 1:00:03And
- 1:00:05and a big reason why I quit I had I had
- 1:00:07a few interactions with Sunny
- 1:00:10throughout the course was because I got
- 1:00:11pulled into his office and basically
- 1:00:13knew I was like this person's a crook.
- 1:00:15Like I don't know what they're doing but
- 1:00:16they're lying. They're there's just
- 1:00:19something wrong here. I don't know
- 1:00:20what's going on but after the
- 1:00:22conversation that I had in his office
- 1:00:24one-on-one
- 1:00:25I quit. I called my dad crying on the
- 1:00:27phone like what what do I do? And I'm
- 1:00:30like I can't work for this company
- 1:00:31anymore. I do not feel good about this.
- 1:00:33Like I'm sorry. I know like I got
- 1:00:35student loans to pay but I'm out of
- 1:00:36here. Like I can't do this.
- 1:00:38Um and
- 1:00:40yeah, he was he was not a good figure in
- 1:00:43the whole story line.
- 1:00:44at all.
- 1:00:46Thanks again for your honesty and for
- 1:00:47your sacrifice. Yeah.
- 1:00:50Uh the gentleman in the balcony.
- 1:00:52Uh first of all, I'd like to thank you
- 1:00:53so much for the wonderful conversation.
- 1:00:56Uh my question revolves around uh your
- 1:00:58guys' experience with regulatory
- 1:01:00agencies and with lawyers. Um I was
- 1:01:03wondering if either of you were heading
- 1:01:05up Medicare or or the FDA or in Erica's
- 1:01:08case the Chinese counterpart of those,
- 1:01:11what would be a regulation you'd want to
- 1:01:13put in place to try to make sure that
- 1:01:15companies like Theranos couldn't rise to
- 1:01:17$10 billion
- 1:01:18before having whistleblowers stop them.
- 1:01:21Wow.
- 1:01:22Ooh, that's tough.
- 1:01:24Um
- 1:01:25I feel like the systems that are in
- 1:01:27place now just need to work better.
- 1:01:29Um like for instance I sent an email
- 1:01:32about the proficiency testing to the
- 1:01:35Center for Medicaid and Medicare
- 1:01:37Services back in 20
- 1:01:40early 2014
- 1:01:42and um they referred me to like like
- 1:01:45basically they referred me to the
- 1:01:46correct department. I I contacted them.
- 1:01:48They said okay, what's the name? They
- 1:01:50said this is cheating. Please let us
- 1:01:51know the name of the company, what tests
- 1:01:53were run, um what dates they were run so
- 1:01:56we can reach out to them and help them
- 1:01:58improve their methods. And I gave them
- 1:02:00all that information and then that email
- 1:02:02just got lost in the shuffle and nothing
- 1:02:05happened.
- 1:02:06Yeah.
- 1:02:06Um
- 1:02:07same thing when CMS came to inspect
- 1:02:09Theranos, they weren't shown the
- 1:02:11Theranos devices.
- 1:02:13They should know that a like a startup
- 1:02:16diagnostic company is going to have some
- 1:02:18not off-the-shelf diagnostic product.
- 1:02:21Um
- 1:02:23but Yeah, it's hard.
- 1:02:26It's hard for regulators too because
- 1:02:28when they're going in they're regulators
- 1:02:30are regulators aren't there to crack
- 1:02:32down on people. That's not really what
- 1:02:34they want to do. They want to like work
- 1:02:35as a system of checks and balances but
- 1:02:37they don't anticipate that a company is
- 1:02:39just going to go to such extreme lengths
- 1:02:41to deceive them.
- 1:02:43Um in terms of new policy that you can
- 1:02:46create
- 1:02:48I I don't even know.
- 1:02:50Like it's it's it's really it's really
- 1:02:52hard to say. I think the policies
- 1:02:54developed tests loophole should be
- 1:02:56closed.
- 1:02:56Oh, yeah. So there's a loophole where so
- 1:02:59people thought that this was regulated
- 1:03:00under the FDA but it's not. It's
- 1:03:02regulated under the Center of Medicaid
- 1:03:05and Medicare Services. And the way that
- 1:03:07LDTs work is that you can actually run
- 1:03:10an LDT for I think 6 months before you
- 1:03:13act have to report it to CLIA.
- 1:03:16Um the thing about Theranos why they
- 1:03:18were a special case is because no one
- 1:03:19anticipated that people would say for
- 1:03:23like HbA1c, right? This this test has
- 1:03:26been around forever. That someone would
- 1:03:29mess it up so bad, right? Because
- 1:03:32I just don't think regulators thought
- 1:03:33that with a test that's existed for like
- 1:03:3650 years now that you would really like
- 1:03:39shake it up so much to to to have that
- 1:03:41much variability and and to have that
- 1:03:43many problems. But it's really it's
- 1:03:45really tough to say what the
- 1:03:47the right policy would be. It's really
- 1:03:49about funding. Like making sure that
- 1:03:50these these organizations have enough
- 1:03:53resources to be able to conduct a proper
- 1:03:56inspection.
- 1:03:59Thank you. The guest with this card.
- 1:04:01Yeah, I'm assuming that you've both read
- 1:04:03Bad Blood and I'm just interested if
- 1:04:05there's anything about the story or the
- 1:04:07book that you were surprised by. And
- 1:04:09then if you can speak more to how you
- 1:04:11think Elizabeth Holmes won all of these
- 1:04:14people over because it is an impressive
- 1:04:16skill to get that many CEOs and
- 1:04:18investors behind you. And there are
- 1:04:20still people who stand behind her. So
- 1:04:22from your perspective
- 1:04:24what it is about her personality and how
- 1:04:27she did that that got so many people
- 1:04:29behind her.
- 1:04:32Mhm.
- 1:04:33Um
- 1:04:35I mean she is she she was extremely
- 1:04:38charismatic. Like I would go into her
- 1:04:41office and she would
- 1:04:43tell me about
- 1:04:44you know, she would tell me about the
- 1:04:46vision of the company and helping third
- 1:04:48world countries and I would I would be
- 1:04:50so motivated to do my job and then I
- 1:04:52would go back and I was working with the
- 1:04:54Theranos device and I go wait, what just
- 1:04:55happened? This is what we were talking
- 1:04:57about that whole time?
- 1:04:59How did she just do that to me? Like I
- 1:05:00was working with this device every day
- 1:05:02but in you know, like a 5-minute
- 1:05:04conversation with her she was able to
- 1:05:06change my mind and for me to feel
- 1:05:08motivated again. Yeah. So I can see how
- 1:05:10if you weren't actually working with the
- 1:05:12device every day how how easy it would
- 1:05:14be for her to convince you that this was
- 1:05:17real and all these things were
- 1:05:18happening. Yeah.
- 1:05:20I
- 1:05:21I think the biggest surprise about Bad
- 1:05:23Blood was like how many people had such
- 1:05:25a like intense crazy experience with
- 1:05:28her. Like there were so many people, so
- 1:05:30many iterations of employees that had
- 1:05:32like worked with her and just been like
- 1:05:34oh my gosh, this is an absolute
- 1:05:36disaster.
- 1:05:37Um and just the whole context of that.
- 1:05:40Like how long that had gone on. Like we
- 1:05:43I had entered the company about 10 years
- 1:05:45after it'd been in existence. That was
- 1:05:47the biggest surprise to me. Like whoa,
- 1:05:49this has been going on for this long.
- 1:05:52And and the fact that like you said she
- 1:05:53had convinced so many people. Part of
- 1:05:55the reason it was able to go on for so
- 1:05:56long is because the turnover of people,
- 1:05:58you know, was was so great where she
- 1:06:00could constantly onboard new people. Um
- 1:06:03but it was a beautiful vision, right? I
- 1:06:05think everyone is dismayed with our
- 1:06:07healthcare system. The fact that it is
- 1:06:09way too expensive. That the fact that
- 1:06:11people can't get a simple blood test
- 1:06:14without breaking the bank is just it's
- 1:06:15just atrocious, right? Like this is it's
- 1:06:17just ridiculous. Um
- 1:06:20so I think
- 1:06:22really that vision is very easy to sell
- 1:06:26and it pulls on the heartstrings of so
- 1:06:28many people. Um you know, people who
- 1:06:31have family members that are sick, who
- 1:06:33have been sick themselves. Uh who've
- 1:06:36financially devastated themselves
- 1:06:38because of the healthcare costs. And
- 1:06:40then also her as a person. It was really
- 1:06:42remarkable, right? We love these kinds
- 1:06:44of stories where you get this person who
- 1:06:46dropped out of Stanford. She had a great
- 1:06:49idea. She worked insanely hard. It like
- 1:06:51really builds up that like American
- 1:06:53meritocracy, you know, like you can just
- 1:06:56like set your mind to any goal and if
- 1:06:59you put in the effort and the energy you
- 1:07:01can make it happen. Um
- 1:07:05yeah. I
- 1:07:07I think uh
- 1:07:09that's probably why she was able to
- 1:07:12bring so many people on board.
- 1:07:17Next question. Okay. Um so you mentioned
- 1:07:19that it was a pretty easy transition to
- 1:07:21like going back to your careers after
- 1:07:23the whole incident was over because like
- 1:07:24you were both whistleblowers, people
- 1:07:26supported you. Um but how do you think
- 1:07:28that the people like the head scientist
- 1:07:29who did know something was wrong for
- 1:07:31years and years and didn't speak out
- 1:07:32about it? Like to your knowledge, how
- 1:07:34were they able to pick up their careers
- 1:07:35again and like have people trust them?
- 1:07:39Um they've been fine. Like Sunny got a
- 1:07:41job and just boggles my mind.
- 1:07:44There's this
- 1:07:45Yeah.
- 1:07:46There's guy who was just, you know,
- 1:07:48basically in on all that. His hands were
- 1:07:49everywhere and he just quit and went and
- 1:07:51got a job at BD. Yeah. I think
- 1:07:54Fun.
- 1:07:55For me it was weird when I immediately
- 1:07:57quit the company it was like a bad
- 1:07:58breakup though because I really I had I
- 1:08:01was so committed to this project. Like
- 1:08:03anyone who knew me working at that job
- 1:08:05like I really wanted it to work and I
- 1:08:07could have seen myself working for that
- 1:08:09company pretty much for the rest of my
- 1:08:10life. Like I really
- 1:08:12uh was onboarded to the mission and when
- 1:08:15I left I became incredibly
- 1:08:17disillusioned. Just like
- 1:08:20yeah, I I completely sort of lost hope
- 1:08:23in in in in faith in these things. But I
- 1:08:27think for most people there's a big
- 1:08:29disassociation between, you know, uh
- 1:08:34what Elizabeth did and and the employees
- 1:08:37within the organization. I think many of
- 1:08:39the employees within the organization,
- 1:08:41they're probably upset just like I was
- 1:08:43where it was like you know, you feel
- 1:08:45very you you feel lied to. You were lied
- 1:08:47to. And and that was it wasn't a good
- 1:08:51experience.
- 1:08:52Um
- 1:08:53but many of them I think can kind of
- 1:08:56learn to grow and and move on from that
- 1:08:58because they're like that's you know,
- 1:09:00she she was kind of a responsible and
- 1:09:02the ringmaster for a lot of of what
- 1:09:05happened.
- 1:09:06But even Elizabeth's brother got a job
- 1:09:08fairly easily.
- 1:09:09Really?
- 1:09:10Yeah. And he knew I mean I'm sure he
- 1:09:12knew what was going on. Yeah.
- 1:09:15So And that's I don't know. People don't
- 1:09:17seem to care.
- 1:09:19And a lot of a lot of these end up that
- 1:09:21way, right? Like even the guy the Wolf
- 1:09:23of Wall Street now is like the
- 1:09:24successful life coach. You're just like
- 1:09:27What in the heck is that? just say?"
- 1:09:30Yeah.
- 1:09:33Uh thank you. Uh my question was on um
- 1:09:36in terms of Elizabeth Holmes' uh
- 1:09:38personality and the way she makes
- 1:09:40statements that she makes, I think we
- 1:09:41see many other like famous figures in um
- 1:09:44Silicon Valley. I mean, Elon Musk and
- 1:09:45many others making these wild
- 1:09:47over-promises. And I'm wondering if you
- 1:09:49see also see those those parallels in
- 1:09:51terms of successful entrepreneurs in
- 1:09:52other fields that who seem to be acting
- 1:09:55just like her, so to speak.
- 1:09:58Mhm.
- 1:10:00I think the difference between Elon Musk
- 1:10:01and Elizabeth Holmes is like Elon Musk
- 1:10:04did deliver on on quite a bit of things,
- 1:10:06you know? Like Yeah.
- 1:10:08You see You can't have go on the road
- 1:10:10anymore without seeing a Tesla kind of
- 1:10:12running about, but um
- 1:10:15uh
- 1:10:16I I think
- 1:10:19it it's interesting how this Silicon
- 1:10:21Valley has been the situate like the
- 1:10:23hero storyline has really prevailed.
- 1:10:25Where
- 1:10:26now instead of, you know, admiring a pop
- 1:10:28star, you now have you can admire
- 1:10:32uh
- 1:10:33uh
- 1:10:34a technology innovator. And we kind of
- 1:10:36hold these people on a certain pedestal
- 1:10:38thinking that they're almost like gods
- 1:10:41when really they're just human like us
- 1:10:43humans like us and they're going to make
- 1:10:44mistakes.
- 1:10:45Um but
- 1:10:47you know, I think
- 1:10:49the striking thing about Elizabeth was
- 1:10:51the fact that it just you know, we held
- 1:10:54her to such esteem, but she wasn't
- 1:10:58producing any results for such a long
- 1:11:00time, right? Like she just did not
- 1:11:01deliver any of the things that she had
- 1:11:04said and she had been dishonest about so
- 1:11:07many things to so many different people.
- 1:11:09Her employees, her investors, and and uh
- 1:11:13her patients.
- 1:11:16How long has started or how long has um
- 1:11:18SpaceX been a company?
- 1:11:21I'm not sure. They Hey, they launched
- 1:11:24and landed
- 1:11:25uh their rocket though. They've They've
- 1:11:27made reusable rockets.
- 1:11:28that's
- 1:11:30That was the goal, right? Wasn't that
- 1:11:31the goal?
- 1:11:32I think so, right?
- 1:11:352002 2002
- 1:11:37So that's like the same time that
- 1:11:38Theranos was founded.
- 1:11:41Yeah. And we couldn't get a machine that
- 1:11:44worked. I know, they couldn't run a
- 1:11:45freaking glucose test.
- 1:11:50The balcony?
- 1:11:51Hi. Um
- 1:11:53I I first of all, I want to commend you
- 1:11:54for your uh honesty and your
- 1:11:57uh courage in doing what you did and
- 1:12:00coming here to talk to us is is a is a
- 1:12:01real treat.
- 1:12:03Uh one of the things I wonder about, I
- 1:12:05don't know how flat the company was in
- 1:12:07terms of management, but
- 1:12:09why do you think I It's easy to
- 1:12:10understand how recent graduates may not
- 1:12:13have had the experience
- 1:12:14to um
- 1:12:16turn on the lights quicker in terms of
- 1:12:18figuring out what was going on,
- 1:12:20but uh
- 1:12:22experienced people should have.
- 1:12:24And uh the question I have is why
- 1:12:27your middle management people weren't
- 1:12:30the ones who actually became the
- 1:12:31whistleblowers.
- 1:12:36I don't know. So many of them had
- 1:12:38families. That's the only thing that
- 1:12:39comes to my mind is just like a lot of
- 1:12:41them had families and
- 1:12:43had the sense of like they they didn't
- 1:12:46want to lose something, you know? They
- 1:12:47were scared Most of them were scared of
- 1:12:49losing their jobs. A lot of them were
- 1:12:50scared of maybe even losing face. Um
- 1:12:54with being with a company that would
- 1:12:56have failed.
- 1:13:00The structure of the management wasn't
- 1:13:02super flat. It was also very fragmented.
- 1:13:06Like your chemistry team didn't
- 1:13:08necessarily talk all the time with your
- 1:13:11immuno assay or your infectious disease
- 1:13:14team.
- 1:13:15Um
- 1:13:16but I think it's just I mean, for us it
- 1:13:18was weird how many people who were
- 1:13:20recent graduates did say something. And
- 1:13:23maybe it was a case cuz we had a lot
- 1:13:25less to lose Yeah. in in in certain
- 1:13:28ways. I think it definitely helps, yeah.
- 1:13:30Having less to lose. But the other thing
- 1:13:31that confuses me is that there were a
- 1:13:33lot of people that I respected who
- 1:13:34stayed at Theranos Yeah. for a long
- 1:13:37time, like past when all these stories
- 1:13:39came out. Yeah. That's confusing to me.
- 1:13:46Um good evening. Thank you. Since we're
- 1:13:48in the biz school, I figured we should
- 1:13:50have at least one sort of finance
- 1:13:51question. And that is uh
- 1:13:54the sort of 9 and 1/2 billion dollar
- 1:13:55valuation was based on some amount of of
- 1:13:59total equity raised, which I I recall
- 1:14:01was in the 8 or 900 million dollar
- 1:14:03range, something like that. So the
- 1:14:05question is is where did all the money
- 1:14:07go, right? So I know they had to cough
- 1:14:10up 40 million back to Walgreens, but
- 1:14:12they took in 140. And I know they paid
- 1:14:15tens of millions or maybe over 100
- 1:14:17million dollars to to Boies and other
- 1:14:19legal firms. Were the salaries
- 1:14:21incredibly high? Did people Were people
- 1:14:23attracted more by stock options? Were
- 1:14:25you know, did did
- 1:14:27Sting and Bono play at company parties?
- 1:14:29Uh
- 1:14:30Where did it go? That's a really good
- 1:14:32question. Definitely the lawyers took a
- 1:14:34lot of it. Yeah. Um I wouldn't be
- 1:14:37surprised if Elizabeth and Sunny took a
- 1:14:39lot of it as well throughout the years.
- 1:14:42Um
- 1:14:44Also
- 1:14:44when they fined her based on the SEC
- 1:14:47violation, they gave her some hand slap
- 1:14:50penalty of what was it? $500,000 or
- 1:14:52something based on what her net worth
- 1:14:54was. So I don't see that she was able to
- 1:14:56liquidate liquidate the assets.
- 1:14:58I don't think she had a very high
- 1:15:00salary. Like someone told me her salary
- 1:15:02was like $250,000 a year. But she took
- 1:15:05out a 25 million dollar loan from the
- 1:15:07company. Yeah. Um
- 1:15:10So she had money in her bank account.
- 1:15:12Got But that still doesn't account for
- 1:15:14where all that money went. The salaries
- 1:15:16weren't insanely high. Yeah. I mean, we
- 1:15:18did have a lot of employees. Biotech in
- 1:15:19general is pretty costly, right? You
- 1:15:21have a bunch of machinery you have to
- 1:15:22buy. Even the like stock items that you
- 1:15:25have, like reagents, when you're
- 1:15:27developing these antibodies, like a
- 1:15:28small little tube of antibody can cost
- 1:15:30you like $6,000.
- 1:15:33Um so the salaries They bought a nice
- 1:15:36pretty little office building.
- 1:15:38the overhead is not cheap. Yeah, that's
- 1:15:40not cheap.
- 1:15:40was a lot.
- 1:15:43Last question, did you ever see her
- 1:15:44blink?
- 1:15:48I don't know.
- 1:15:49I don't Yeah, I don't know.
- 1:15:54Hi. So you talked about how your
- 1:15:56grandfather was on the board of
- 1:15:58Theranos. And I can't imagine if you
- 1:16:01ever went to him and told him, you know,
- 1:16:03like I don't believe what's going on
- 1:16:05here or it's kind of a scam,
- 1:16:08he would have an easy time believing
- 1:16:09you. So I'm wondering, were there people
- 1:16:11around you guys that simply had a tough
- 1:16:14time believing you? And did they ever
- 1:16:16say sorry?
- 1:16:18Um lots of people had a hard time
- 1:16:20believing.
- 1:16:22Um
- 1:16:24Yeah. I mean, we saw it from kind of
- 1:16:26like the back end. Like when the first
- 1:16:28paper came out, it was like when the
- 1:16:31Wall Street Journal first broke the
- 1:16:32story,
- 1:16:33you know, at this point neither of us
- 1:16:35were on the record and we saw it and we
- 1:16:36saw the response of like, "Oh, of
- 1:16:38course, you know, they're trying to
- 1:16:40target her. It's because she's
- 1:16:41successful. They're targeting her
- 1:16:43because she's a woman." Like, you know,
- 1:16:46this is like classic tactics by the
- 1:16:48media to build another sensational story
- 1:16:51so they can make more money. So we
- 1:16:53definitely saw a lot of pushback on what
- 1:16:56was happening. I had even, you know,
- 1:16:58personal friends of mine who are
- 1:17:00entrepreneurs here that said, "Oh, yeah,
- 1:17:02it's because she's a woman. That's why
- 1:17:04that they're attacking her because
- 1:17:05they're trying to, you know, just take
- 1:17:07down various women in tech."
- 1:17:10Um so we we kind of saw like the
- 1:17:12sentiment really shift and slam down.
- 1:17:16Like kudos to John because he really
- 1:17:18stacked up those stories in a really
- 1:17:20intelligent way to make sure like the
- 1:17:22first one I was pretty underwhelmed. I
- 1:17:24was like, "Oh, man. Like this is kind of
- 1:17:26technical. A lot of people aren't going
- 1:17:28to understand what this means."
- 1:17:30Um but then just
- 1:17:32all the lies he was able to unravel um
- 1:17:36and show
- 1:17:37people like the depth of deception that
- 1:17:40was that was occurring. Um but it took a
- 1:17:42long time for like the consensus of
- 1:17:44people to realize like, "Okay, this
- 1:17:46isn't an attack on her. It's really like
- 1:17:50she has just lied this much and there
- 1:17:52are just so many problems that have been
- 1:17:53occurring in this company." It took a
- 1:17:55long while to to change people's
- 1:17:57sentiment in that direction.
- 1:18:01The balcony?
- 1:18:02So I'm actually really interested in the
- 1:18:04psychology of being in an environment
- 1:18:06where you've identified that things
- 1:18:09aren't right. But everyone around you
- 1:18:10seems to accept that it's totally
- 1:18:12normal. And it seems to me that both of
- 1:18:14you were able to be like, "Nope, I'm
- 1:18:16going to trust my gut on this."
- 1:18:18But I'm curious if you have advice for
- 1:18:19people who maybe aren't able to trust
- 1:18:21themselves as well or feel like they're
- 1:18:24the ones taking crazy pills because
- 1:18:25everyone else is just business as usual.
- 1:18:28And like how do you
- 1:18:30how do you basically follow your gut and
- 1:18:31do what's right when it feels like
- 1:18:34you're the one who's wrong?
- 1:18:38I I had the feeling of that I was wrong
- 1:18:41for quite quite some time. Like I really
- 1:18:43left there. I I I didn't know if I was
- 1:18:45wrong. I was like, "No, there's there's
- 1:18:47something wrong going on here,
- 1:18:49but maybe there is something I'm not
- 1:18:51seeing."
- 1:18:52Um because you were just surrounded by
- 1:18:55so many talented people. I just couldn't
- 1:18:58I I really felt that
- 1:19:00uh there was something that I wasn't
- 1:19:03seeing. I think honestly, if I had
- 1:19:06stayed within the company, I would have
- 1:19:09probably more likely not
- 1:19:11done something because I would have been
- 1:19:13so It's It's so hard to say. I have no
- 1:19:15idea. But you're so easily swayed by uh
- 1:19:18again, that culture, like the fear
- 1:19:21that's sort of implemented in there and
- 1:19:22then everyone else kind of being very um
- 1:19:27uh just nonchalant about what was going
- 1:19:30on just kind of going through the
- 1:19:31motions and the grind of the everyday
- 1:19:33even though knowing that there's a lot
- 1:19:35of problems.
- 1:19:36Um but I don't know. I don't know if I
- 1:19:38have a very good answer for
- 1:19:39never thought that I was wrong. Like I
- 1:19:41never had a doubt.
- 1:19:44And the part of it was that that were
- 1:19:46all the senior scientists around me were
- 1:19:48seeing the same things and I would go to
- 1:19:49them and and they would say like yep,
- 1:19:51you're that's what you're seeing.
- 1:19:53Yeah. But it's mostly like it was it's
- 1:19:55kind of weird like the culture is mostly
- 1:19:57brushed off. Tons of people made jokes
- 1:19:58about it.
- 1:20:00Um
- 1:20:01but not that many people really did
- 1:20:02anything about it but
- 1:20:04I really never doubted that I was right.
- 1:20:07Mhm.
- 1:20:08And I don't know how to tell someone
- 1:20:10who's doubting themselves to just Yeah.
- 1:20:13Know you're right.
- 1:20:15I don't know.
- 1:20:18Yeah, I don't know. I don't know how you
- 1:20:19would take that that switch.
- 1:20:21I guess just
- 1:20:23just accumulating enough evidence,
- 1:20:24right? And asking other people like hey,
- 1:20:27is this right? For me it was really
- 1:20:29talking to lawyers and regulators. And
- 1:20:31then it was like oh, okay. Yeah. Um
- 1:20:34uh these these intuitions that you had
- 1:20:37about what was going on
- 1:20:38um can be easily confirmed by by kind of
- 1:20:42experts in that field.
- 1:20:46Gentleman here.
- 1:20:47So part of what I think this makes makes
- 1:20:48the story so fascinating is how badly it
- 1:20:50went wrong. And one of the things that
- 1:20:51makes me curious about is do you think
- 1:20:53Elizabeth went in knowing she was going
- 1:20:55to lie and cheat her way if necessary?
- 1:20:57And if not, kind of where do you think
- 1:20:59it went wrong?
- 1:21:02I don't think she went in this to just
- 1:21:04lie and deceive. I really think that she
- 1:21:06initially went in with good intentions
- 1:21:08and I don't know where it went wrong and
- 1:21:10it's so tragic to me that it went wrong
- 1:21:13and that so much money was wasted and
- 1:21:15that now it's put this like sort of
- 1:21:17scorn around diagnostic projects where
- 1:21:20they're
- 1:21:21not getting funded as easily and a lot
- 1:21:23of people have a lot of skepticism
- 1:21:24around uh like point of care diagnostics
- 1:21:27and everything but I have no idea. I
- 1:21:30think
- 1:21:31it just again she just over promised so
- 1:21:34much and just didn't know how to deliver
- 1:21:36and had so much capital that she was
- 1:21:38able to
- 1:21:39just kind of bide her time
- 1:21:42for a long time but I really don't know.
- 1:21:44I think she just really wanted to be
- 1:21:46Steve Jobs so she created a world where
- 1:21:48she was Steve Jobs.
- 1:21:50Um
- 1:21:51but it does seem kind of short-sighted.
- 1:21:54Um I think she wasn't
- 1:21:57I think she just wasn't able to let go
- 1:21:59to admit, okay, this isn't working. I
- 1:22:02just think she was just not capable of
- 1:22:05of doing that. Yeah.
- 1:22:07And there's that very popular psychology
- 1:22:09that runs through this world that if you
- 1:22:11like just believe something hard enough
- 1:22:13that it'll come into fruition, right?
- 1:22:15We've seen Oprah and all these like
- 1:22:17successful people kind of take this this
- 1:22:19mentality that you know, if I just
- 1:22:21really wish it into being and I just
- 1:22:24like visualize myself being at my end
- 1:22:27goal, somehow that's just it's just
- 1:22:29going to work out. And
- 1:22:32I don't know. I feel like her and maybe
- 1:22:34the people she surrounded herself with
- 1:22:36kind of
- 1:22:38just like fed into that delusion for so
- 1:22:40long that they couldn't break break out
- 1:22:42of it and just face reality of what was
- 1:22:44sitting right there in front of them.
- 1:22:46Yeah. It's kind of funny because
- 1:22:48investors want to invest in someone who
- 1:22:50says failure is not an option.
- 1:22:52But
- 1:22:53it's really I feel like investors should
- 1:22:56tell
- 1:22:57you know, their CEOs failure is an
- 1:22:59option. Yeah.
- 1:23:02Um and and it's okay. I think investors
- 1:23:04have to be okay with failures. I think
- 1:23:06CEOs have to be okay with failures.
- 1:23:08Um and she was definitely of the mindset
- 1:23:12failure is not an option.
- 1:23:16Which is detrimental.
- 1:23:19I think we have time for one more
- 1:23:20question.
- 1:23:22Well, I guess this is I should conclude
- 1:23:23this. Failure of this question should be
- 1:23:25an option. There's a lot of pressure. Um
- 1:23:27but thank you for coming in. I had a
- 1:23:29question about something you said
- 1:23:30earlier about this kind of hero worship
- 1:23:32um which is definitely present in
- 1:23:33Elizabeth Holmes people people hailing
- 1:23:35her as the next Steve Jobs and all of
- 1:23:36that. First of all, hero worshiping
- 1:23:37Steve Jobs and then hero worshiping her
- 1:23:39based on this vision of her as Steve
- 1:23:40Jobs.
- 1:23:42With this and Elon Musk and all these
- 1:23:44other people um in Silicon Valley who we
- 1:23:47look up to and often fall are are fall
- 1:23:50from grace later on like Steve Jobs was
- 1:23:52made out to be a bad manager later on in
- 1:23:54a biography. Elon Musk is kind of gone
- 1:23:56off the rails a little bit. Um
- 1:23:59how closely do you think we should tie
- 1:24:01these people to their company and should
- 1:24:04we predicate our belief on how good they
- 1:24:06are as a person on how successful their
- 1:24:08company is? Because you said earlier
- 1:24:10that Theranos failed but SpaceX and
- 1:24:12Tesla are successful um but there have
- 1:24:14been multiple pieces saying that the
- 1:24:15working conditions there are very bad
- 1:24:17anyway even despite their success. So I
- 1:24:20just wondered if you could talk about
- 1:24:21that a little bit more.
- 1:24:24Yeah.
- 1:24:25Uh it's hard to kind of pull them away
- 1:24:27from their company because
- 1:24:29like people like that just spend all
- 1:24:31their time on their companies so
- 1:24:34I don't know how you separate. Like
- 1:24:35Elizabeth was Theranos. Yeah. Like the
- 1:24:37two cannot be separated.
- 1:24:40Yeah.
- 1:24:40Steve Jobs is Apple or was Apple.
- 1:24:43Um
- 1:24:45But it's not the case majority of
- 1:24:46companies that's not actually the case
- 1:24:48cuz in the US actually what you see is a
- 1:24:50lot of founders actually get replaced
- 1:24:52and will they'll have like an actual
- 1:24:55managing CEO run their company in most
- 1:24:57cases. And it's weird there've just been
- 1:24:59these few people that have ma- managed
- 1:25:01to really link themselves
- 1:25:03to their companies and become the
- 1:25:05identity of that organization. People
- 1:25:07like Elon Musk, um people like Steve
- 1:25:10Jobs. But I I I think it's the minority
- 1:25:13more than it is the majority uh uh of
- 1:25:17people that kind of are these really
- 1:25:20strong idols and leaders of their
- 1:25:22companies. And I don't know, maybe they
- 1:25:24use Twitter more or maybe I don't even
- 1:25:26know why that happens but yeah.
- 1:25:31I'm not too sure. Please join me in
- 1:25:33thanking Tyler, Erica, and Susanna.
About this transcript
This page contains the full transcript of Spilling the Blood of a Silicon Valley Unicorn | Tyler Shultz and Erika Cheung: 2019 by McCoy Family Center for Ethics in Society, generated from the public captions YouTube serves with the video. The transcript has 15,145 words across 2,422 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.
What you can do with it
Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to translate the transcript into 100+ languages.
Free YouTube transcript tool
YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, translation to 100+ languages, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.